Filing Flows › Nuvation Bio (NUVB) › Recalls, complaints & regulation
Nuvation Bio (NUVB): clinical trials
Nuvation Bio (NUVB) beyond its filings: 9 active clinical trials.
Nuvation Bio's latest quarter
Nuvation Bio, Q3 2026: revenue $45.0M (+243% year over year), operating margin -93.9%, net loss $41.9M, operating cash flow −$38.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Nuvation Bio have?
9 active studies on ClinicalTrials.gov, 4 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.